{"timestamp": 1771604708.2350636, "value": {"ticker": "NRSN", "company_name": "NeuroSense Therapeutics Ltd.", "short_name": "NeuroSense Therapeutics Ltd.", "sector": "Healthcare", "industry": "Biotechnology", "country": "Israel", "market_cap": 29473738, "float_shares": 16495421, "shares_outstanding": 29699319, "short_ratio": 2.03, "short_percent_of_float": 0.0194, "shares_short": 559856, "shares_short_prior": 555312, "insider_percent_held": 0.19156, "institution_percent_held": 0.01036, "total_cash": 666000, "total_debt": 0, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0, "current_ratio": 0.706, "book_value": -0.021, "price_to_book": -42.385715, "operating_cashflow": -8385000, "free_cashflow": -6569250, "price": 0.8901, "52w_high": 2.6, "52w_low": 0.68, "avg_volume": 338793, "avg_volume_10d": 152500, "full_time_employees": 17, "audit_risk": 0, "overall_risk": 0}}